These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 25369341)

  • 1. Utilization of an automated pipetting system in the cell line-based screening of the activity of a DNA-damaging anti-tumour drug.
    Suchánková T; Ovesná P; Samadder P; Souček K
    Folia Biol (Praha); 2014; 60 Suppl 1():50-5. PubMed ID: 25369341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a high-throughput and automated cancer cell proliferation panel for oncology lead optimization.
    Lei M; Ribeiro H; Kolodin G; Gill J; Wang YS; Maloney D; Fan Y; Li S; Myer L; Beluch M; Zhang L; Schweizer L
    J Biomol Screen; 2013 Oct; 18(9):1043-53. PubMed ID: 23733846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.
    Danovi D; Folarin AA; Baranowski B; Pollard SM
    Methods Enzymol; 2012; 506():311-29. PubMed ID: 22341231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?
    Friedrich J; Ebner R; Kunz-Schughart LA
    Int J Radiat Biol; 2007; 83(11-12):849-71. PubMed ID: 18058370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
    Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
    J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based bioluminescence screening assays.
    Amante RJ; Badr CE
    Methods Mol Biol; 2014; 1098():185-95. PubMed ID: 24166378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
    Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
    Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated soft agar assay for the high-throughput screening of anticancer compounds.
    Thierbach R; Steinberg P
    Anal Biochem; 2009 Apr; 387(2):318-20. PubMed ID: 19454240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
    Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
    J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues.
    Drewitz M; Helbling M; Fried N; Bieri M; Moritz W; Lichtenberg J; Kelm JM
    Biotechnol J; 2011 Dec; 6(12):1488-96. PubMed ID: 22102438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
    Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
    Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening.
    Chen MC; Gupta M; Cheung KC
    Biomed Microdevices; 2010 Aug; 12(4):647-54. PubMed ID: 20237849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
    Griffiths M; Sundaram H
    Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbioreactors for high-throughput cytotoxicity assays.
    Yang ST; Zhang X; Wen Y
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):111-27. PubMed ID: 18175274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing.
    Sanz L; Pascual M; Muñoz A; González MA; Salvador CH; Alvarez-Vallina L
    Microvasc Res; 2002 May; 63(3):335-9. PubMed ID: 11969310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4D Tumorigenesis Model for Quantitating Coalescence, Directed Cell Motility and Chemotaxis, Identifying Unique Cell Behaviors, and Testing Anticancer Drugs.
    Kuhl S; Voss E; Scherer A; Lusche DF; Wessels D; Soll DR
    Methods Mol Biol; 2016; 1407():229-50. PubMed ID: 27271907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of automated cell-based protocols for toxicity testing of biomaterials.
    Ferreira MV; Jahnen-Dechent W; Neuss S
    J Biomol Screen; 2011 Jul; 16(6):647-54. PubMed ID: 21518824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.